< Zurück zu den aktuellen Neuigkeiten & Events

Artikel

Opposition case studies

Mai 2020

With an increasing number of European patents being granted year on year, freedom to operate for third parties has never been so important. When a patent application is filed at the European Patent Office (EPO), upon grant it becomes a bundle of national patents and subject to national patent laws. For third parties looking to clear the way, this can prove very complicated. Different countries may have differences in national laws and invalidation procedures which may lead to different outcomes.

The EPO offers an efficient and cost effective post grant opposition procedure, whereby within nine months of grant a third party can centrally challenge the European patent. If successful, the patent is then revoked (or amended) across all countries in which it is in force. Oppositions can therefore avoid the potential inconsistency of challenging patents nationally and at a fraction of the price. The official fee for filing an EPO opposition is currently 815 EUR, with attorney fees typically in the tens of thousands of EUR, as opposed to hundreds of thousands or even millions for national litigation.

The statistics on opposition outcomes at the EPO are also generally favourable to the challenger, with just over two thirds of patents opposed either being revoked or amended.

A further advantage of the system is that there is no litigation estoppel. Oppositions can also be filed in the name of a strawman, which is potentially commercially significant. For example the European patent attorney filing the opposition or even another company, to conceal the true identity of the opponent.

Early Certainty From EPO Oppositions

Oppositions at the EPO have a very well-established procedure.

  • Response – After the opposition nine-month filing window ends, a deadline is then set for the patentee to file a response to any oppositions filed.
  • Summons to Oral Proceedings – This includes a non-binding preliminary opinion of the Opposition Division (a panel of three EPO members). This sets a deadline for patentee and opponent(s) to file final written submissions. Typically this might include the patentee filing substitute claim sets (Auxiliary claim sets).
  • Hearing – The Summons also sets the date for an oral hearing for all parties to attend at the EPO in the Hague, Munich or Berlin. It is at this hearing all parties have a final opportunity to plead their case with a decision being announced by the Opposition Division at the end of the hearing. The outcome, which is effective the same day, is either:
    – the patent is revoked; or
    – the opposition is rejected; or
    – the patent is maintained in an amended form, for example on the basis of a substitute claim set.
  • Written Decision – This is then issued within a few months of the hearing, including minutes from the oral hearing.

Following feedback from users of the system, in July 2016 the EPO introduced a streamlined procedure aiming to cut the overall duration of ”straightforward” cases to 15 months from expiry of the opposition filing period (i.e. within two years of grant). This does not involve removing any of the above mentioned steps, but instead the EPO optimising its internal workflows. The mean average duration of opposition proceedings as recently reported for 2019 is just over 18 months.

Opposition timelines

Appeals and Rule Changes

Within two months of the opposition written decision being issued, any party adversely affected can appeal. Procedurally, an appeal follows a similar route to oppositions. It typically culminates in an oral hearing held at the EPO Board of Appeal premises in Haar, Germany. The statistics show that appeals are also relatively successful with half or even more opposition decisions being altered as a result.

Appeal proceedings, however, on average have a longer duration compared to oppositions – almost twice the length. In order to address this and provide more consistency, the Rules of the Boards of Appeal were updated effective 1 January 2020. As well as introducing a number of procedural efficiencies, the changes relate to restricting the appeal to the contents of the opposition. This makes it more difficult to introduce new arguments or documents which were not part of the opposition proceedings.

Conclusion

The EPO opposition procedure is undoubtedly a hugely valuable tool for third parties seeking freedom to operate within Europe. Cost-effective, consistent and time-efficient. In the light of oppositions speeding up and the recent change to the appeal rules, challengers should aim to put their best case forward from the outset.

This article was prepared by HGF Partners Leythem Wall and Mike Nelson. If you would like further advice on this or any other matter, please contact Leythem or Mike.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Aktuelle Neuigkeiten

Event - 5. Mai 2026

IP‑Klinik für KMU bei ETZ EnergyWorks

Wir freuen uns, eine kostenlose Klinik für geistiges Eigentum (IP) ankündigen zu können, die am Mittwoch, den 27. Mai, von 11:00 bis 16:00 Uhr bei ETZ EnergyWorks in Aberdeen stattfindet …

Veranstaltungsdetails

Managing IP EMEA Awards

HGF celebrates five wins at the Managing IP EMEA Awards, recognising its strength as a leading European IP firm HGF is delighted to announce that the firm has won five …

Weiterlesen

WIPR Leaders 2026

Wir sind stolz darauf bekannt zu geben, dass vier unserer Anwälte im WIPR Leaders Directory 2026 ausgezeichnet wurden: Pieter de ruijter Rebecca Field Lee Curtis Richard Wylie Garreth Duncan Das …

Weiterlesen

Wir feiern unsere neuen Partner

Wir freuen uns sehr, bekannt zu geben, dass HGF mit Wirkung zum 1. Mai fünf Kolleginnen und Kollegen zu Partnern ernannt hat. Dieser wichtige Meilenstein würdigt nicht nur ihre individuellen …

Weiterlesen
Event - 11. bis 12. Mai 2026

HGF ist stolz darauf, am 14th Microbiome R&D and Business Collaboration Forum: Europe sowie am 8th Skin Microbiome and Cosmeceuticals Congress: Europe teilzunehmen.

HGF ist stolz darauf, am 14th Microbiome R&D and Business Collaboration Forum: Europe sowie am 8th Skin Microbiome and Cosmeceuticals Congress: Europe teilzunehmen. Die Veranstaltung findet am Montag, den 11., …

Veranstaltungsdetails
Event - 27. April 2026

HGF ist stolz darauf, Gold Sponsor des IP Counsel Café zu sein

HGF ist stolz darauf, Gold Sponsor des IP Counsel Café zu sein, das vom 12. bis 14. Mai im Silicon Valley, USA, stattfindet. Die HGF‑Partnerin Susan Keston wird zum Thema …

Veranstaltungsdetails

Sieben HGF-Anwälte in der Pro Bono Recognition List 2026 ausgezeichnet

Wir freuen uns, bekannt zu geben, dass sieben unserer Anwälte in die Pro Bono Recognition List 2026 für England & Wales aufgenommen wurden. Damit werden diejenigen gewürdigt, die im vergangenen …

Weiterlesen

PRESSEMITTEILUNG Oliver Pooley tritt am 21. April 2026 als Partner bei HGF ein.

HGF freut sich, die Ernennung von Oliver Pooley bekannt zu geben, der dem Unternehmen am 21. April 2026 als Partner beitreten wird. Oliver verstärkt die Technology & Engineering Group von …

Weiterlesen